AP2009004849A0 - Pyrazole analogs - Google Patents
Pyrazole analogsInfo
- Publication number
- AP2009004849A0 AP2009004849A0 AP2009004849A AP2009004849A AP2009004849A0 AP 2009004849 A0 AP2009004849 A0 AP 2009004849A0 AP 2009004849 A AP2009004849 A AP 2009004849A AP 2009004849 A AP2009004849 A AP 2009004849A AP 2009004849 A0 AP2009004849 A0 AP 2009004849A0
- Authority
- AP
- ARIPO
- Prior art keywords
- pyrazole analogs
- pyrazole
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86733706P | 2006-11-27 | 2006-11-27 | |
| PCT/IB2007/003518 WO2008065493A1 (en) | 2006-11-27 | 2007-11-14 | Pyrazole analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2009004849A0 true AP2009004849A0 (en) | 2009-06-30 |
Family
ID=39226772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2009004849A AP2009004849A0 (en) | 2006-11-27 | 2007-11-14 | Pyrazole analogs |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US7772269B2 (es) |
| EP (1) | EP2097407A1 (es) |
| JP (1) | JP4469924B2 (es) |
| KR (1) | KR20090074264A (es) |
| CN (1) | CN101541790A (es) |
| AP (1) | AP2009004849A0 (es) |
| AR (1) | AR063924A1 (es) |
| AU (1) | AU2007327004A1 (es) |
| BR (1) | BRPI0718672A2 (es) |
| CA (1) | CA2667566C (es) |
| CL (1) | CL2007003403A1 (es) |
| CO (1) | CO6180447A2 (es) |
| CR (1) | CR10745A (es) |
| CU (1) | CU23801B7 (es) |
| DO (1) | DOP2009000121A (es) |
| EA (1) | EA016588B1 (es) |
| EC (1) | ECSP099328A (es) |
| GE (1) | GEP20125386B (es) |
| GT (1) | GT200700104A (es) |
| HN (1) | HN2007000505A (es) |
| IL (1) | IL198412A0 (es) |
| MA (1) | MA30924B1 (es) |
| MX (1) | MX2009005526A (es) |
| NO (1) | NO20092413L (es) |
| NZ (1) | NZ576376A (es) |
| PE (1) | PE20081299A1 (es) |
| RS (1) | RS20090211A (es) |
| TN (1) | TN2009000205A1 (es) |
| TW (1) | TW200831495A (es) |
| UA (1) | UA92833C2 (es) |
| UY (1) | UY30743A1 (es) |
| WO (1) | WO2008065493A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009069044A1 (en) | 2007-11-26 | 2009-06-04 | Pfizer Inc. | Pyrazole derivatives as 5-lo inhibitors |
| EP2151450A1 (de) * | 2008-07-29 | 2010-02-10 | Sandoz AG | Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden |
| WO2011137363A1 (en) * | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
| US8759386B2 (en) * | 2011-01-24 | 2014-06-24 | Boehringer Ingelheim International Gmbh | Pyrazole compounds as CRTH2 antagonists |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
| CA2163667C (en) | 1993-06-14 | 1998-12-15 | Rodney W. Stevens | Imidazole lipoxygenase inhibitors |
| US5883106A (en) | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
| SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
| JP3400392B2 (ja) * | 1994-10-18 | 2003-04-28 | ファイザー製薬株式会社 | ５−リポキシゲナーゼ阻害剤及び新規医薬組成物 |
| DE69611101T2 (de) | 1995-09-18 | 2001-04-05 | Pfizer | Imidazol lipoxygenase inhibitoren |
| US6194585B1 (en) * | 1998-12-22 | 2001-02-27 | Pfizer Inc. | Process for preparing 5-lipoxygenase inhibitors |
| JP2001100686A (ja) * | 1999-09-28 | 2001-04-13 | Hitachi Kokusai Electric Inc | 表示データ取込方法及び比較検査装置 |
| JP2001100682A (ja) * | 1999-09-28 | 2001-04-13 | Sanyo Electric Co Ltd | サインシステム |
-
2007
- 2007-11-14 EP EP07848899A patent/EP2097407A1/en not_active Withdrawn
- 2007-11-14 EA EA200970422A patent/EA016588B1/ru not_active IP Right Cessation
- 2007-11-14 RS RSP-2009/0211A patent/RS20090211A/sr unknown
- 2007-11-14 BR BRPI0718672-0A patent/BRPI0718672A2/pt not_active IP Right Cessation
- 2007-11-14 JP JP2009538801A patent/JP4469924B2/ja not_active Expired - Fee Related
- 2007-11-14 AP AP2009004849A patent/AP2009004849A0/xx unknown
- 2007-11-14 AU AU2007327004A patent/AU2007327004A1/en not_active Abandoned
- 2007-11-14 UA UAA200903927A patent/UA92833C2/ru unknown
- 2007-11-14 KR KR1020097010726A patent/KR20090074264A/ko not_active Application Discontinuation
- 2007-11-14 CN CNA2007800432018A patent/CN101541790A/zh active Pending
- 2007-11-14 GE GEAP200711271A patent/GEP20125386B/en unknown
- 2007-11-14 NZ NZ576376A patent/NZ576376A/en not_active IP Right Cessation
- 2007-11-14 WO PCT/IB2007/003518 patent/WO2008065493A1/en active Application Filing
- 2007-11-14 MX MX2009005526A patent/MX2009005526A/es active IP Right Grant
- 2007-11-14 CA CA2667566A patent/CA2667566C/en not_active Expired - Fee Related
- 2007-11-23 AR ARP070105216A patent/AR063924A1/es not_active Application Discontinuation
- 2007-11-26 PE PE2007001660A patent/PE20081299A1/es not_active Application Discontinuation
- 2007-11-26 GT GT200700104A patent/GT200700104A/es unknown
- 2007-11-26 UY UY30743A patent/UY30743A1/es not_active Application Discontinuation
- 2007-11-26 TW TW096144833A patent/TW200831495A/zh unknown
- 2007-11-26 US US11/944,732 patent/US7772269B2/en not_active Expired - Fee Related
- 2007-11-26 HN HN2007000505A patent/HN2007000505A/es unknown
- 2007-11-27 CL CL200703403A patent/CL2007003403A1/es unknown
-
2009
- 2009-04-23 CR CR10745A patent/CR10745A/es not_active Application Discontinuation
- 2009-04-27 IL IL198412A patent/IL198412A0/en unknown
- 2009-05-13 EC EC2009009328A patent/ECSP099328A/es unknown
- 2009-05-15 CU CU20090083A patent/CU23801B7/es not_active IP Right Cessation
- 2009-05-20 CO CO09051941A patent/CO6180447A2/es not_active Application Discontinuation
- 2009-05-22 TN TNP2009000205A patent/TN2009000205A1/fr unknown
- 2009-05-26 DO DO2009000121A patent/DOP2009000121A/es unknown
- 2009-05-27 MA MA31925A patent/MA30924B1/fr unknown
- 2009-06-24 NO NO20092413A patent/NO20092413L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1130780A1 (en) | Pyrazoles as 11-beta-hsd-1 | |
| EP2166849A4 (en) | SUBSTITUTED PYRAZOL COMPOUNDS | |
| ZA201100471B (en) | Pyrazole compounds 436 | |
| GB0608263D0 (en) | Compounds | |
| GB0602424D0 (en) | Compounds | |
| GB0602046D0 (en) | Compounds | |
| GB2441396B (en) | Indoline-sulfonamides compounds | |
| GB0614070D0 (en) | Compounds | |
| GB0614066D0 (en) | Compounds | |
| EP1984379A4 (en) | ANTI-ARENAVIRAL COMPOUNDS | |
| IL192799A0 (en) | Substituted 4-phenylpiperidines | |
| EP2084135A4 (en) | pyrazole | |
| IL195074A0 (en) | Imidazoazepinone compounds | |
| GB0625604D0 (en) | Compounds | |
| EP2082022A4 (en) | COMPOUNDS | |
| IL197078A0 (en) | Ouinolinylmethyl compounds | |
| IL198412A0 (en) | Pyrazole analogs | |
| ZA200903382B (en) | Substituted 4-imidazoles | |
| EP2004174A4 (en) | NAPHTHALENEDIONED COMPOUNDS | |
| GB0602042D0 (en) | Compounds | |
| EP1973905A4 (en) | COMPOUNDS | |
| GB0608688D0 (en) | Compounds | |
| AP2009004767A0 (en) | Cubstituted azolin-2-yl-amino compounds | |
| EP2016069A4 (en) | BISPYRIDINIUMVERBINDUNGEN | |
| GB0602412D0 (en) | Compounds |